Skip to main content

NHS Next Stage Review

Volume 464: debated on Wednesday 10 October 2007

To ask the Secretary of State for Health (1) what his most recent estimate is of the (a) cost to date (i) in total and (ii) broken down by major cost area and (b) expected overall cost to the public purse of Lord Darzi's NHS Next Stage Review; (156415)

(2) what progress Lord Darzi is making in his NHS Next Stage Review; how many (a) clinicians, (b) managers and (c) other staff he has received representations from; how many NHS organisations the review team has formally met with since the announcement of the review; whether he still intends to publish an interim report of the work of the review in October; and if he will make a statement;

(3) how many clinical pathway groups to inform the work of the NHS Next Stage Review have been established in each strategic health authority; and who the members are of each group which has been established.

The interim report, published on 4 October, explains that the review is primarily a local process involving thousands of frontline staff, patients and public in the design of care pathways based on best practice evidence. This is core business for the national health service and as such involves no additional cost to the taxpayer.

The success of a review like this depends of course on the thorough involvement of patients, public and staff and good communication. The total departmental spend so far on staff, patients and public engagement in direct connection with the review is £1.2 million.

The clinicians, managers and other staff leading the review work locally are receiving the great majority of representations from clinicians, managers and other staff.

Lord Darzi personally has met with over 1,500 NHS staff in 17 NHS organisations, read more than 1,400 letters and e-mails from people, including NHS staff, from up and down the country and participated in a nationwide day of detailed discussions with 1,000 people including NHS staff from nine towns and cities. An event attended by representatives of 250 stakeholder groups has been held. In addition, officials at the Department of Health regularly meet with representatives from NHS organisations on various issues right across the span of the review.

Each strategic health authority is responsible for establishing eight local clinical pathway groups. Lists of members should be sought directly from the strategic health authorities themselves.